Impella Analyses Show Lower Mortality in High-Risk Heart Procedures
Photo: TokenPost
Johnson & Johnson said three clinical analyses found lower mortality rates among patients who received Impella support for high-risk coronary procedures than the rates reported in the recent CHIP-BCIS3 trial. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
